- Home
- PTGX vs ASTH Comparison
PTGX vs ASTH Comparison
Compare PTGX & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- ASTH
- Stock Information
- Founded
- PTGX 2006
- ASTH 1994
- Country
- PTGX United States
- ASTH United States
- Employees
- PTGX N/A
- ASTH N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- ASTH Professional Services
- Sector
- PTGX Health Care
- ASTH Consumer Discretionary
- Exchange
- PTGX Nasdaq
- ASTH Nasdaq
- Market Cap
- PTGX 2.8B
- ASTH 2.2B
- IPO Year
- PTGX 2016
- ASTH N/A
- Fundamental
- Price
- PTGX $47.91
- ASTH $55.47
- Analyst Decision
- PTGX Strong Buy
- ASTH Strong Buy
- Analyst Count
- PTGX 7
- ASTH 6
- Target Price
- PTGX $52.83
- ASTH $64.40
- AVG Volume (30 Days)
- PTGX 450.1K
- ASTH 269.1K
- Earning Date
- PTGX 11-08-2024
- ASTH 11-07-2024
- Dividend Yield
- PTGX N/A
- ASTH N/A
- EPS Growth
- PTGX N/A
- ASTH 45.24
- EPS
- PTGX 2.75
- ASTH 1.44
- Revenue
- PTGX $319,120,000.00
- ASTH $1,591,829,000.00
- Revenue This Year
- PTGX $400.33
- ASTH $33.99
- Revenue Next Year
- PTGX N/A
- ASTH $24.43
- P/E Ratio
- PTGX $17.54
- ASTH $38.79
- Revenue Growth
- PTGX 125.73
- ASTH 22.76
- 52 Week Low
- PTGX $13.76
- ASTH $28.87
- 52 Week High
- PTGX $48.89
- ASTH $63.20
- Technical
- Relative Strength Index (RSI)
- PTGX 60.40
- ASTH 47.69
- Support Level
- PTGX $45.33
- ASTH $54.81
- Resistance Level
- PTGX $48.89
- ASTH $57.09
- Average True Range (ATR)
- PTGX 1.28
- ASTH 1.75
- MACD
- PTGX 0.11
- ASTH -0.71
- Stochastic Oscillator
- PTGX 77.11
- ASTH 22.13
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.